YS Biopharma Co., Ltd. Q3 2024 Earnings Call Transcript
| YSDelisted Stock | 0.48 0.03 5.88% |
Slightly above 61% of YS Biopharma's investor base is looking to short. The analysis of current outlook of investing in YS Biopharma Co, suggests that many traders are alarmed regarding YS Biopharma's prospects. YS Biopharma's investing sentiment can be driven by a variety of factors including economic data, YS Biopharma's earnings reports, geopolitical events, and overall market trends.
YS Biopharma |
Operator Ladies and gentlemen, thank you for standing by and welcome to YS Biopharma
Read at insidermonkey.com
 |
YS Biopharma Fundamental Analysis
We analyze YS Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of YS Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of YS Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
YS Biopharma is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
YS Biopharma Co, Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with YS Biopharma stock to make a market-neutral strategy. Peer analysis of YS Biopharma could also be used in its relative valuation, which is a method of valuing YS Biopharma by comparing valuation metrics with similar companies.
Peers
YS Biopharma Related Equities
| QNRX | Quoin Pharmaceuticals | 21.33 | ||||
| ALLR | Allarity Therapeutics | 6.93 | ||||
| IMMX | Immix Biopharma | 6.67 | ||||
| REVB | Revelation Biosciences | 4.72 | ||||
| CNSP | Cns Pharmaceuticals | 1.82 | ||||
| ZURA | Zura Bio | 2.80 | ||||
| SONN | Sonnet Biotherapeutics | 3.97 | ||||
| VRAX | Virax Biolabs | 4.29 | ||||
| ZVSA | ZyVersa Therapeutics | 4.35 | ||||
| CDIO | Cardio Diagnostics | 6.98 | ||||
| BDRX | Biodexa Pharmaceticals | 8.72 |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in YS Biopharma Stock
If you are still planning to invest in YS Biopharma Co, check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the YS Biopharma's history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |